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The cranial base exerts a supportive role for the brain and includes the occipital, sphenoid and ethmoid
bones that arise from cartilaginous precursors in the early embryo. As the occipital bone and the
posterior part of the sphenoid are mesoderm derivatives that arise in close proximity to the notochord
and ﬂoor plate, it has been assumed that their development, like the axial skeleton, is dependent on
Sonic hedgehog (Shh) and modulation of bone morphogenetic protein (Bmp) signalling. Here we
examined the development of the cranial base in chick and mouse embryos to compare the molecular
signals that are required for chondrogenic induction in the trunk and head. We found that Shh
signalling is required but the molecular network controlling cranial base development is distinct from
that in the trunk. In the absence of Shh, the presumptive cranial base did not undergo chondrogenic
commitment as determined by the loss of Sox9 expression and there was a decrease in cell survival.
In contrast, induction of the otic capsule occurred normally demonstrating that induction of the cranial
base is uncoupled from formation of the sensory capsules. Lastly, we found that the early cranial
mesoderm is refractory to Shh signalling, likely accounting for why development of the cranial base
occurs after the axial skeleton. Our data reveal that cranial and axial skeletal induction is controlled by
conserved, yet spatiotemporally distinct mechanisms that co-ordinate development of the cranial base
with that of the cranial musculature and the pharyngeal arches.
& 2012 Elsevier Inc. All rights reserved.Introduction
The cranial base, a supportive and protective structure under-
lying the brain of gnathostomes, arises from multiple cartilagi-
nous condensations which expand and fuse to form a united
structure running from the foramen magnum posteriorly to the
interorbital junction anteriorly. At the midline three bones, the
occipital, sphenoid and ethmoid, are formed which extend later-
ally to unite with other cartilaginous elements including the
developing nasal, otic and optic capsules (Vorster, 1989;
McBratney-Owen et al., 2008). The cranial base is formed from
both neural crest and mesoderm (Couly et al., 1993; McBratney-
Owen et al., 2008). Fate mapping studies in chicks and mice have
shown that the structures that are formed anterior to the
notochord (i.e. prechordal cranium) are derived from neural crest
whilst, the post-chordal (posterior) cranial base is derived from
the mesoderm (Couly et al., 1993; Evans and Noden, 2006;
McBratney-Owen et al., 2008; Wada et al., 2011). In both micell rights reserved.
. Francis-West).and chicks, the prechordal:postchordal interface lies within the
basisphenoid bone and the ethmoid bone is entirely neural crest
derived, whilst the occipital bone is derived from somitic and
unsegmented cranial mesoderm (Couly et al., 1993; McBratney-
Owen et al., 2008).
The post-chordal or posterior cranial base develops in close
proximity to the notochord and ventral neural tube and it is
assumed that these tissues induce its formation in a fashion
analogous to the induction of the axial skeleton. In the trunk,
formation of the sclerotome, the progenitor of the vertebrae,
requires Hedgehog signalling from the notochord, ﬂoor plate and
endoderm, together with Noggin/Gremlin antagonism of Bmp
signalling (Christ et al., 2004; Dockter, 2000; Fan and Tessier-
Lavigne, 1994; McMahon et al., 1998; Monsoro-Burq, 2005;
Stafford et al., 2011; Zhang et al., 2001). Previous studies have
suggested some degree of similarity between trunk and cranial
base skeletal development. In mice and zebraﬁsh, Shh and the
chondrogenic marker Sox9 are expressed in adjacent tissues and
loss of Shh signalling following cyclopamine treatment or genetic
inactivation of components of the Shh signalling pathway affect
the development of the cranial base (Jeong et al. 2004; Nie et al.,
2005; Eberhart et al., 2006; Schwend and Ahlgren, 2009; Wada
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crest derived trabecular cartilages which give rise to the ethmoid
bone, appear to be the most susceptible (Wada et al., 2005;
Eberhart et al., 2006; Koyama et al., 2007; Aoto et al., 2009;
Schwend and Ahlgren, 2009). The timing of when Shh signalling is
required in cranial base development, together with its speciﬁc
role, is unknown.
It is also known that head and trunk mesoderm display
different histological and molecular characteristics expressing
distinct sets of genes (Bothe and Dietrich, 2006; Hacker and
Guthrie, 1998). This suggests that the response of the head
mesoderm to speciﬁc signals might be different from that of the
trunk. This has been clearly highlighted by comparison of axial
versus craniofacial myogenesis: in the head, Wnt signalling acts to
prohibit myogenic commitment in contrast to the trunk where
Wnt signalling is required for this process (reviewed by Bryson-
Richardson and Currie, 2008; Noden and Francis-West, 2006).
Here, we have examined the development of the cranial base
with the aim of understanding the signals that control its
formation and how its development compares temporally to the
musculoskeletal system of the trunk and pharyngeal arches. The
head:trunk divide falls at the occipito-cervical boundary interface
and therefore, the cranial base includes the occipital bone,
sphenoid and ethmoid bones. Speciﬁcally we compared the
development of the cranial base to that of the trunk axial skeleton
in chick and mouse embryos. We found that, as for myogenesis,
formation of the cranial skeleton occurs later than the trunk
skeleton and involves a unique molecular repertoire. However,
we show the role of Shh signalling is conserved during vertebrae
and cranial base development and that posterior cranial base
development occurs later than the axial skeleton because the
early cranial mesoderm is refractory to Shh signalling. We
propose this delay is necessary to allow expansion of the brain
and also to co-ordinate development of the cranial base with that
of the musculoskeletal system of the pharyngeal arches.Materials and methods
Chick and mouse embryos
Fertilised White Leghorn chicken eggs (Henry Steward & Co.
Ltd, Lincolnshire, UK) were incubated at 3871 1C and staged as
described by Hamburger and Hamilton (1951). Wild type and
Shh-/- E11.5 and E12.5 mouse embryos were generated as
described (Chiang et al., 1996). Embryos were ﬁxed in 4%
paraformaldehyde and were either analyzed by in situ hybridiza-
tion for gene expression, histological staining or immunolabeling.In situ hybridisation to whole mounts and tissue sections
Embryos were processed into methanol for whole mount
in situ hybridisation or into wax for in situ hybridisation to tissue
sections. Whole-mount in situ hybridisation using digoxigenin-
labelled RNA probes and in situ hybridisation to tissue sections
using 35S-labelled RNA riboprobes were performed as described
by (Dastjerdi et al., 2007). Chick probes were synthesised as
described previously: cShh (Johnson et al., 1994), cPtc1 and cPtc2
(Pearse et al., 2001), cSox9 and cCollagen type II (Healy et al.,
1999), cGli1 and cGli3 (Marigo et al., 1996), cGli2 (Schweitzer et al.,
2000), cPax1 (Muller et al., 1996), cBapx1 (Rodrigo et al., 2003),
cIhh (Vortkamp et al., 1996), cCollagen type X (Oshima et al., 1989),
cBmp2 and cBmp4 (Francis-West et al., 1994). Mouse probes were
synthesised as described previously: mSox9 and mCollagen II
(Zhao et al., 1997), Ptc1 (Goodrich et al., 1996).Embryonic manipulations
Afﬁ-Gel Blue agarose beads (BioRad) were incubated with
1 mg/ml of recombinant murine Noggin, Dickkopf 1, or Sfrp2
(R&D Systems) for 1 h at 37 1C and were applied into the cranial
mesoderm adjacent to the mesencephalon of HH stage 10 chick
embryos (Supplementary Fig. 1A). Trunk notochords isolated from
the level of somites 5–10 (1 being the most rostral somite) of HH
stage 10 chick embryos were transplanted into the cranial
paraxial mesoderm adjacent to the mesencephalon of HH stage
10 chick embryos (Supplementary Fig. 1B). Rostral notochord
from the level of the mesencephalon was also transplanted
ectopically in the cranial mesoderm as above (Supplementary
Fig. 1B) or into the trunk between the neural tube and the somite
in the prospective lumbar region. Stage HH13/14 chick embryos
were treated with cyclopamine (1 mg/ml cyclopamine (Sigma) in
45% solution of 2-hydroxypropyl-b-cyclodextrin (HBC) in PBS) in
ovo according to (Cordero et al., 2004). A 45% solution of
2-hydroxypropyl-b-cyclodextrin in PBS was used as a control of
HBC toxicity. The embryos were allowed to develop for 24 h and
ﬁxed for in situ hybridization and immunolocalisation analyses to
whole mounts or tissue sections.
Immunohistological studies
Immunohistological studies were carried out on parafﬁn ﬁxed
tissues following standard protocols. Sections were dewaxed in
xylene for 30 min and rehydrated through a decreasing ethanol
series into ddH2O for 5 min each. Antigen retrieval was carried
out by boiling the slides in 10 mM sodium citrate buffer pH 9.0 for
10 min. Antibodies (Rabbit polyclonal phospho-Smad 1/5/8
(Cell Signalling Technology), phospho-Histone H3 (NEB), cleaved
Caspase 3 (NEB)) were used at a 1:100 dilution. Sections were
incubated with the primary antibody overnight at 4 1C. Sub-
sequently, the sections were rinsed three times in 1xPBS
for 5 min each. Secondary antibody solution (Alexa Fluor 488
(Invitrogen) diluted at 1:1000 concentration) was applied for 1 h
at room temperature and the sections were washed as previously.
Sections were mounted in ProLong Gold Antifade mounting
medium (Invitrogen).
Histological analysis
Tissue sections were stained with Haematoxylin and Eosin or
Alcian Blue 8GX according to standard protocols.Results
Cranial base and trunk have distinct temporal developmental
patterns and molecular signatures
To compare the initial stages of cranial base and axial skeleton
development, we carried out whole-mount in situ expression
analyses of key molecular signals known to be essential for
sclerotome development, including the homeobox-containing
genes Pax1 and Bapx1 and the chondrogenic markers Sox9, type
II collagen, Sox5 and Sox6 in HH stage 10 chick embryos. We
focused on these genes because Pax1 induces the expression of
Bapx1 in the sclerotome (Rodrigo et al., 2003) that, in turn,
induces and maintains the expression of Sox9 (Murtaugh et al.,
2001; Zeng et al., 2002). Interestingly, we found that Bapx1 was
expressed in the unsegmented mesoderm of the developing
cranial base in the absence of Pax1 expression (Fig. 1A and B)
and that Pax1 expression was restricted to the pharyngeal
endoderm (white arrow in Fig. 1A0). In addition, the cranial
Fig. 1. Chondrogenic commitment occurs later in the developing cranial base relative to the trunk axial skeleton. Whole-mount in situ hybridisation analysis showing the
expression of Pax1 (A), Bapx1 (B), Sox9 (C), Sox5 (D), Sox6 (E) and type II collagen (F) in HH stage 10-11 chick embryos. A–F are dorsal views of the embryo, A0–F0 and A00–F00
are transverse sections at the levels indicated in A–F through the cranial unsegmented mesoderm and trunk paraxial mesoderm respectively. The notochord is arrowed in
A0–F0 whilst the sclerotome is arrowed in A00–F00 . White arrows in A0 and B0 indicate the cranial endoderm and mesoderm, respectively. Arrowheads in C0 , D0 and F0 indicate
cranial neural crest cells.
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and type II collagen at this stage although these factors were
expressed in the migrating cranial neural crest cells (Fig. 1C–F;
arrowhead in C0, D0 and F0). In contrast, Pax1 and Bapx1 were co-
expressed in the developing sclerotome that, as expected, dis-
played also very strong expression of Sox9, Sox5, Sox6 and type II
collagen (Fig. 1C–F; C00–F00). The Sox5, Sox6, Sox9 and type II collagen
genes were expressed in the notochord at every anatomical
location examined (Fig. 1, black arrows in C0–F0). Clearly the
cranial mesoderm displays a unique molecular proﬁle and a delay
in chondrogenesis when compared to trunk mesoderm.Histological and molecular analyses of cranial base development
We then investigated later stages of development by histolo-
gical and molecular analyses to determine when the cranial base
starts to form and the timing and rate of differentiation. Embryos
ranging from HH stage 18 to HH stage 36, when terminal
differentiation has occurred in the axial and appendicular skele-
ton, were ﬁrst analysed histologically by H&E and alcian blue
staining. In chicks, several embryonic cartilages form at the
midline which include the parachordal cartilage at the level of
the mesencephalon, the acrochordal cartilage at the tip of the
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the notochord (Romanoff, 1960). Caudal to the parachordal
cartilage, the occipital somites also condense to contribute to
the basi-occipital and exo-occipital cartilages (Romanoff, 1960;
Couly et al., 1993).
At HH stage 18 the developing cranial base largely consisted of
disorganised loose mesenchyme surrounding the notochord
(Fig. 2A). The ﬁrst morphological signs of cranial base became
apparent by HH stage 21 when a region of higher cellular
density—likely representing the developing acrochordal
cartilage—was present at the rostral tip of the notochord and
adjacent to Rathke’s pouch (arrowheads in Fig. 2B). At this stage
the parachordal cartilages, which develop adjacent to the noto-
chord, were not appreciable morphologically (Fig. 2B). By HH
stage 24, the acrochordal, parachordal and optic cartilages were
readily visualised by H&E and alcian blue staining, the latter
indicative of the production of cartilaginous matrix (Fig. 2C, D and
E; Fig. 3M; data not shown). The posterior region of the para-
chordal cartilage, which contributes to the basisphenoid bone,
encompassed the notochord (arrowed in Fig. 2D) and was not yetFig. 2. Histological analysis of the development of the cranial base. Frontal (A, E and F)
18 (A), 21 (B), 25 (C, D and E) and 27 (F) chick embryos stained with haemotoxylin a
parachordal and occipital cartilages in (C). The notochord is arrowed in (A–D). The arrow
arrowheads demarcate the acrochordal cartilage in (B), Rathke’s pouch in (C), the parach
acrochordal cartilage; e, eye; p, parachordal cartilages; and rp, Rathke’s pouch.fused with the developing basioccipital cartilages derived from
the paraxial mesoderm of the occipital somites. The boundary is
marked by the arrowheads in Fig. 2D. However, rostrally the
parachordal cartilages were now fused with the developing
acrochordal cartilages, which had also started to expand across
the medial–lateral axis (Fig. 2E; data not shown). By HH stage 27,
the trabeculae cartilages, representing the most anterior cartilages
of the cranial base, had formed (Fig. 2F; Supplementary Fig. 2C;
Wada et al., 2011). The occipital cartilages derived from the
occipital somites were still distinct from the developing parachor-
dal cartilage at HH stage 27, but were fused by HH stage 30, uniting
the cranial base along the anterior-posterior axis (Supplementary
Fig. 2D and E). By HH stage 36, the acrochordal and parachordal
cartilages increased in size across the medio-lateral axis to unite
with the optic and otic capsules, respectively (Supplementary
Fig. 2L; data not shown). At this stage the chondrocytes were
morphologically immature and there was no obvious sign of pre-
hypertrophy or hypertrophy.
Tissue sections from representative stages and locations were
processed for in situ hybridisation analysis. Bapx1 expression wasand saggital sections (B, C and D) through the developing cranial base of HH stage
nd eosin (A–D) or alcian blue (E and F). (D) shows a higher power image of the
s in (E) and (F) indicate the parachordal and trabecular cartilages respectively. The
ordal:occipital cartilage boundary in (D) and the developing optic capsules in (E). a,
Fig. 3. Chondrogenic commitment in the developing cranial base coincides with the activation of Shh signalling. (A–F) show vibratome sections of chick embryos following
whole-mount DIG in situ hybridisation. (G, M and S) show alcian blue stained tissue sections, together with adjacent tissue sections (H, I, K and L; N–R and T–X
respectively) probed for gene expression by radioactive in situ hybridisation. The sections show the expression of Sox9 (A, H, N and T), type II collagen (B, I, O and U), Ptc2
(C, K, Q and W), Ptc1 (D, L, R and X), Gli1 (E), Gli2 (F) and Bapx1 (J, P and V), in the developing cranial base of stage 15 (C–F), 17 (A), 18 (B, G, H, I, K and L), 19 (J), 24 (M–R) and
30 (S–X) chick embryos. A–L are transverse sections through the developing cranial base whilst (M–X) are sagittal sections. A–X, the arrows indicate the developing cranial
base. In M, the upper arrow indicates the acrochordal cartilage and the lower arrow, the parachordal cartilage. B, brain; M, mandibular primordia; and v, vertebrae
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cartilages from HH stage 18 to stage 30 (Fig., 3J and P). Its
expression appeared slightly lower in the acrochordal cartilage
by HH stage 30 and was also down-regulated along the midline of
the cranial base (Fig. 3V; data not shown). Expression of the
chondrogenic genes Sox9 and type II collagen was apparent at
every stage studied (Fig. 3A, B, H, I, N, O, T and U; Supplementary
Fig. 2F, G, M and N). Interestingly, Ihh, a marker of prehypertophic
chondrocytes, was not detected until HH stage 36 (Supplemen-
tary Fig. 2H and O) and type X collagen, a marker of terminal
chondrocyte maturation, was still not expressed (Supplementary
Fig. 2I). This is in dramatic contrast to the axial and appendicular
skeleton where Ihh and type X collagen expression are activated
within 72 h of the initial chondrogenic commitment (data not
shown) and in contrast to the pharyngeal arch cartilages that had
reached hypertrophy by HH stage 36 (Supplementary Fig. 2I).
Therefore, in addition to the later onset of chondrogenic induc-
tion, the developing cranial base is also characterized by a delay
in cartilage maturation and hypertrophy, analogous to the differ-
ence in the rate of myogenic differentiation between the head and
trunk reported in previous studies (Noden and Francis-West,
2006; Noden et al., 1999). Although the parachordal cartilages
are thought to arise as two separate condensations that subse-
quently fuse along the midline, we found no molecular or
histological evidence for any distinct condensations along the
medial-lateral axis. Similarly, McBratney-Owen et al., 2008 did
not observe two separate condensations during their analysis of
cranial base development in mice and they suggested that the
two independent ‘‘entities’’ may fuse at the prechondrogenic
stages. Therefore, differentiation of the parachordal cartilages
appears to occur directly around the notochord, which is a
process distinct from chondrogenic induction in the trunk which
occurs at a distance from the notochord. In the trunk committed
sclerotomal cells then migrate towards and surround thenotochord. In contrast to the acrochordal and parachordal carti-
lages, the trabecular cartilages did clearly develop as two separate
entities (Fig. 2F; also see Wada et al., 2011).
Activation of shh signalling coincides with chondrogenic commitment
within the cranial mesoderm
Despite the molecular/temporal differences with trunk meso-
derm, the posterior cranial base arises in close proximity to the
notochord, and we hypothesized that Shh signalling would still be
required for its development analogous to Shh roles in trunk
chondrogenesis. To address this possibility, we examined expres-
sion of the Hh receptors Ptc1 and Ptc2 and down-stream effectors
Gli1, -2 and -3. Ptc1, -2 and Gli1 are transcriptional targets of
the Shh signalling pathway and therefore, their expression is
indicative of Shh signalling activity (Goodrich et al., 1996; Pearse
et al., 2001).
At HH stage 15, Ptc1, Ptc2, Gli1 and Gli2 transcripts were clearly
detected in the cranial paraxial mesoderm (Fig. 3C–F) and thus,
their expression precedes the onset of Sox9 and collagen type II
expression which occurs at HH stage 17 (Fig. 3A and B) supporting
the possibility that Shh signalling plays a role in the development
of the posterior cranial base (Nie et al., 2005; Koyama et al., 2007).
Expression of Ptc2, in association with Sox9 and type II collagen
expression, continued throughout the developing cranial base
until at least HH stage 30 (Fig. 3K, Q and W). In contrast, Ptc1
expression was down-regulated and negligible between HH
stages 20 to 30 (Fig. 3L, R and X). At HH stage 36, Ptc1 and Ptc2
were both expressed in the perichondrial cells of the cranial base
(Supplementary Fig. 2J, K, P and Q), and Ptc2was also expressed in
the chondrocytes adjacent to the notochord (Supplementary
Fig. 2Q). Curiously, activation of Shh signalling did not coincide
with chondrogenic commitment within the otic and optic capsule
(Supplementary Fig. 2A and B; data not shown).
Fig. 4. The Shh signalling pathway is not active in the early cranial mesoderm. DIG—in situ hybridisation showing the expression of Ptc1 (A), Ptc2 (B), Gli1 (C), Gli2 (D) and
Gli3 (E) in HH stage 10 chick embryos. A–E are dorsal views of whole embryos and A0–E0 and A00–E00 are vibratome sections at the level indicated. The black arrows in A0–E0
indicate the cranial notochord, which is in the centre of the presumptive cranial base, whilst the red arrows indicate expression in the neural tube. The arrows in A00–D00
indicate the developing sclerotome. The arrow in E00 indicates the dermomyotome.
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coincide with, and be required for, early cranial base develop-
ment, we analysed younger embryos. At HH stage 10, Ptc1 and
Ptc2 expression was already robust in the sclerotome (Fig. 4A00
and B00) and cranial ventral neural tube (Fig. 4A0 and B0), but
expression in the cranial mesoderm was very weak and limited to
a small number of cells immediately adjacent to the notochord
and the ﬂoor plate (Fig. 4A0 and B0). Gli1 transcripts were clearly
detected in developing sclerotome and cranial neural tube, but
were not detectable in the cranial paraxial mesoderm at HH stage
11 (Fig. 4C0 and C00). In the trunk, high levels of Gli2 and Gli3
expression were detected in the dorsal somite (Fig. 4D00 and E00)
and in the head their expression was detected within the neuraltube and migrating neural crest cells (Fig. 4D0 and E0). Therefore,
there was no indication of Shh signalling activity within the
presumptive cranial base at these stages. Since Shh is expressed
throughout the anterior-posterior axis of the notochord and the
ﬂoor plate of the neural tube (Supplementary Fig. 3A–A00) the
combined data suggest that in contrast to the trunk paraxial
mesoderm, the cranial mesoderm is not competent to respond to
Shh signalling at HH stage 10-11 but becomes competent to
respond by HH stage 15. Thus, the cranial mesoderm becomes
responsive to Hh signalling over developmental time and this
onset of competence just precedes induction of the cranial base.
To investigate if the cranial base also develops later than the
trunk axial skeleton in mammals and if chondrogenic commitment
Fig. 5. Shh signalling and development of the mammalian cranial base. DIG—in situ hybridisations to saggital (A–F) and frontal (G–J) tissue sections through E10.5 (A–C),
E11.5 (D–F) and E12.5 (G–J) wildtype (A–F, G and I) and Shh-/- mutant (H and J) mouse embryos probed for the expression of Ptc1 (A and D), Sox9 (B, E, G and H), and type II
collagen (C, F, I and J). Arrows in (D–J) indicate the cranial base and arrowheads in (G and H) point to the otic capsule condensations. cb, developing cranial base; o, otic
capsule; and v, vertebrae.
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analysis of Sox9, type II collagen and Ptc1 expression in developing
mouse embryos. We found that Ptc1, Sox9 and type II collagen are
not detectable in the cranial base at E10.5, although they are
expressed in the developing sclerotome (Fig. 5A–C; data not
shown). Ptc1 expression was ﬁrst detectable in the presumptive
cranial base at E11.5 (Fig. 5D), when Sox9 and type II collagen
expression was also ﬁrst apparent (Fig. 5E and F, also see Nie et al.,
2005; McBratney-Owen et al., 2008). This contrasts dramatically
with the trunk where Sox9 expression was readily detectable
within the sclerotome at E9.5 (Zhao et al., 1997; data not shown).
Thus, in the mouse the onset of chondrogenesis in the cranial base
also occurs later than in the trunk and coincides with responsive-
ness to Shh signalling (Fig. 5D and E).
Shh is required for cranial base development
Because chondrogenic differentiation in cranial mesoderm
deﬁned by Sox9 and type II collagen expression coincides with
activation of Shh signalling, it suggests that, as for the axial trunk
skeleton, Shh signalling is actually required for chondrogenic
development (Chiang et al., 1996; Zhang et al., 2001; Stafford
et al., 2011). To investigate this possibility, we ﬁrst examined
cranial base development in E11.5 and E12.5 Shh-/- mutant mice.
At these stages in wild type embryos, the cartilage condensations
of the cranial base and early chondrogenesis are apparent,
respectively (Fig. 5G and I; data not shown). DIG in situ hybridisa-
tion analysis revealed that the expression of Sox9 and type II
collagen in the presumptive cranial base was negligible/absent in
Shh-/- embryos at both E11.5 and E12.5 (E11.5, n¼2; E12.5, n¼3;Fig. 5H and J; data not shown), although expression of both Sox9
and type II collagen was detectable in the developing neural tube
and otic capsule (compare Fig. 5G and I with Fig. 5H and J; data
not shown). No hypertrophic chondrocytes were observed, and
cells in the presumptive cranial base were all mesenchymal/
ﬁbroblastic in appearance ruling out the possibility that in the
absence of Shh signalling chondrocyte differentiation had been
accelerated (data not shown).
As the notochord degenerates in Shh-/- mutants (Chiang et al.,
1996), the absence of cranial base development may be due to a
loss of notochordal factors other that Shh. It may also reﬂect
requirements for Shh earlier in development. Therefore, we also
examined the role of Hh signalling as the cranial base is forming
using the chick embryo as a model system when we can speciﬁ-
cally inactivate Shh signalling just prior to the development of the
cranial base. In this case, HH stage 13 chick embryos were exposed
to cyclopamine, an antagonist of Hedgehog signalling, and were
analysed at stage HH 18/19. Control embryos were treated with
hydroxy-b-cyclodextrin. The treated embryos were analysed for
the expression of Ptc1, Ptc2 and/or Gli1 by DIG in situ hybridization
to tissue sections. Embryos showing negligible expression of these
transcriptional targets were analysed for the expression of chon-
drogenic markers on adjacent tissue sections (Fig. 6E).
Treated embryos appeared narrower along the medial-lateral
axis compared to control treated embryos, consistent with the
role of Shh signalling during expansion of the midline (compare
Fig.6A–D with Fig. 6E–H). Expression of Sox9 (n¼4/4), type II
collagen (n¼3/3) and Sox5 (n¼2/2) was negligible in the pre-
sumptive cranial base (Fig. 6F–H), although type II collagen was
expressed in the notochord and cranial ectoderm indicating the
Fig. 6. Shh signalling is required for cranial base development in the chick. Transverse sections through HH stage 18 chick embryos that have been treated with
cyclopamine (E–H, J and L) or the control solution (A–D, I and K) showing the expression of Ptc2 (A, E), Sox9 (B, F), type II collagen (C,G) and Sox5 (D,H). Sections (I–L) have
been immunostained with antibodies against phospho Histone H3 (I and J) or activated Caspase 3 (K and L) to identify proliferating and apoptotic cells respectively. The
long arrows indicate the notochord; the short arrows in L indicate apoptotic cells clustered around the notochord. O, otic vesicle; and t, trigeminal ganglion.
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tive cranial base (Fig. 6G). In contrast, control treated embryos
showed robust expression of these markers in the developing
cranial base (Sox9 (n¼3/3), type II collagen (n¼3/3) and Sox5
(n¼2/2)) (Fig. 6A–D). As Sox9 and type II collagen are speciﬁcally
expressed during early chondrogenesis, we also considered the
possibility that Sox9 and type II collagen down-regulation resulted
from the premature differentiation of the cranial base in the absence
of Hh signalling. However, we did not observe the presence of
differentiated chondrocytes in H&E stained cyclopamine-treated
embryos (data not shown). Thus loss of Hh signalling impedes the
initiation of chondrogenesis in the cranial base of both mouse and
chick embryos.Loss of HH signalling results in increased cell death in the cranial base
To assess whether changes in cell survival and/or proliferation
could contribute to the failure of chondrogenic commitment
during interference with Hh signalling, cyclopamine and control
treated chick embryos were immunostained for activated Caspase
3 and phospho Histone H3 respectively. Clusters of apoptotic cells
were present around the notochord and in developing pharyngeal
arches in cyclopamine treated, but not in control, embryos
(Fig. 6K and L, n¼3). Cell proliferation was slightly, but signiﬁ-
cantly increased, in the developing cranial base of cyclopamine
treated embryos compared to the controls (Fig. 6I and J, n¼3). Shh
has been shown to promote cell cycle progression at the G1 phase
and the G2/M transition and the increase in the numbers of cells
positive for phospho Histone H3, which marks the G2/M phase,
may reﬂect delayed cell cycle progression in the absence of Shh.
Alternatively, as chondrogenic commitment would normally
result in a decrease in cell proliferation, this increase may also
be a secondary consequence of the inhibition of chondrogenic
commitment in the cranial base of cyclopamine treated embryos.Why does the cranial base develop later than the trunk axial
skeleton?
Given that Shh is expressed throughout the anterior-posterior
axis of the notochord and neural tube (Supplementary Fig. 3), it
was curious that cranial base development occurs later than the
trunk skeleton. We considered three possible explanations. First,
there may be antagonists of Shh signalling in the early cranial
mesoderm and surrounding tissues that inhibit Shh function.
Second, there may be qualitative/quantitative differences in the
ability of the notochord/ﬂoor plate to signal, as suggested by a
study examining the notochordal regulation of Pax1 expression
(Muller et al., 1996). Third, the distinct cranial molecular code
may be prohibitive for Shh signalling. To test these possibilities,
we carried out the following two sets of experiments.
Several studies have shown that Bmp action and canonical Wnt
signalling can antagonize Shh signalling including during sclero-
tome induction (Stafford et al., 2011). Thus, we analysed Bmp-2, -4
and -7 expression and activity during early cranial chick develop-
ment. We found that Bmp7 is expressed in the ﬂoor plate
throughout the developing midbrain and hindbrain i.e. adjacent
to the developing posterior cranial base at HH stage 10 (Fig. 7C;
data not shown). Bmp2 is weakly expressed in the ﬂoor plate
(Fig. 7A). In contrast, Bmp4 is expressed in the neural folds and
neural crest and is not in close proximity to the developing cranial
base (Fig. 7B). Immunohistochemistry showed phospho-Smads1,
5 and 8 (indicative of active Bmp signalling) were present in stage
10 cranial mesoderm, whereas Smad activity was lower when Shh
signalling is initiated within the cranial mesoderm by HH stage 15
(Fig. 7D–G; data not shown). Likewise, Wnts are expressed in the
cranial ectoderm and neural tube (Tzahor et al., 2003). This
suggested that the Bmp and the canonical Wnt signalling pathways
may antagonise Shh signalling in the early cranial mesoderm.
To investigate this hypothesis, beads pre-soaked in the Bmp
antagonist Noggin or the Wnt antagonist Dkk1 (or Sfrp2) were
Fig. 7. Wnts and Bmps do not antagonise Shh signalling in the early cranial mesoderm. (A–C) and (H–J) are vibratome sections through the cranial base of HH stage 10
(A–C) and 13/14 (H–J) chick embryos showing the expression of (A) Bmp2, (B) Bmp4, (C) Bmp7, (H) Gli1, (I) Ptc2 and (J) Ptc1. In (H–J) beads soaked in (H) Noggin, (I) Sfrp2 or
(J) both Noggin and Sfrp2 have been placed into the cranial mesoderm of HH stage 10 embryos which were then allowed to develop for 24 h. (D–G) are immunolocalisation
studies showing Smad1, 5 and 8 activity in the developing cranial base at HH stage 10 (D), DAPI stain, (E) Smad localisation and (F) the overlay of (D) and (E). (G) is the
negative control. The arrows in (A, D, E and H–J) indicate the developing cranial base and in (C), the cranial endoderm. The arrowhead in (I) indicates induction of gene
expression within the neural tube. cb, cranial base; e, endoderm; fp, ﬂoor plate; n, notochord; and nt, neural tube.
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the level of the midbrain. Embryos were allowed to develop for
24 h until HH stage 13/14 when they were analysed by whole-
mount in situ hybridisation for Ptc1, Ptc2 and Gli1 expression.
None of these treatments resulted in premature or ectopic
activation of Ptc1 (Noggin 3/3, Dkk 2/2, Sfrp2 2/2), Ptc2 (Noggin
4/4, Dkk 3/3, Sfrp2 5/5) or Gli1 (Noggin 5/5, Dkk 2/2, Sfrp2 6/6)
(Fig. 7H and I). Furthermore, simultaneous application of Noggin
and Sfrp2 did not activate the Shh signalling pathway either
(Fig. 7J; Ptc1 2/2, Ptc2 2/2, Gli1 2/2). As positive controls we
conﬁrmed the activity of the recombinant proteins by testing
their ability to down-regulate Wnt11 expression in the somite
(Dkk1, Sfrp2) and Msx1 expression in the developing facial
primordia (Noggin, data not shown). We also determined the
expression patterns of Gas1, Hip1 and Rab23, other potential
antagonists of the Shh signalling pathway, and found no detect-
able expression in the cranial mesoderm (data not shown).
Together, the data suggest that neither Bmp nor canonical Wnt
signalling inhibits the Shh pathway in the early cranial meso-
derm. Unlike chondrogenic initiation in the sclerotome, antagon-
ism of Bmp signalling may not be required for induction of
chondrogenesis within the developing cranial base.
The cranial and caudal notochord has similar ability to activate the
shh signalling pathway
The absence of transcriptional targets of Shh signalling in the
early cranial mesoderm may indicate that Shh expressed by the
notochord is not secreted and/or modiﬁed appropriately or that
the early cranial mesoderm is unresponsive to Shh signalling.
To examine these possibilities, we tested the ability of the cranial
versus caudal notochord to activate Ptc/Gli1 expression when
grafted into the trunk and cranial mesoderm respectively. We
also examined the ability of the cranial notochord to activate Shh
signalling in the neural crest derived mesenchyme in the head.Activation of the Shh signalling pathway was determined 24 h
later by whole-mount in situ hybridisation for the transcriptional
targets of Shh: Ptc1, Ptc2 and Gli1.
Grafting of the posterior trunk notochord into the head
activated the Shh signalling pathway in the lateral neural-crest
derived mesenchyme and ectopically within the neural tube
(Fig. 8A–C; Ptc1 2/2, Ptc2 2/2, Gli1 4/4). However, within the
presumptive cranial base, the ectopic trunk notochord did not
strongly activate or signiﬁcantly increase Shh signalling. This is
dramatically illustrated in Fig. 8C where the ectopic notochord is
in close proximity to the developing cranial base. Ectopic Gli1
transcription was strongly activated in the lateral cranial neural-
crest derived mesenchyme and neural tube, but there was no
detectable Gli1 expression in the developing cranial base either
around the endogenous notochord or adjacent to the ectopic
notochord. In the embryos shown in Fig. 8A and B there was a
slight increase in the expression of the transcriptional targets of
Hh signalling within the cranial mesoderm on the side with the
ectopic notochord. However, the levels of Ptc1, Ptc2 and Gli1
expression were much lower than those induced in the neural
crest-derived mesenchyme (arrowed), suggesting that the cranial
mesoderm is in fact relatively refractory to Hh signalling.
This conclusion was further supported by the grafts of a cranial
notochord into the trunk that strongly induced the expression of
Shh transcriptional targets within the paraxial mesoderm (Fig. 8D
and E; Ptc1 1/1, Ptc2 2/2). Likewise, grafts of a cranial notochord
ectopically within the head were able to activate Shh signalling in
surrounding tissues although again activation of Shh signalling
targets was higher lateral to the ectopic notochord i.e. in the
neural crest derived mesenchyme (Fig. 8F; n¼4/4). This rules out
the possibility that Shh is not secreted from the cranial notochord,
for example, due to the absence of Dispatched necessary for Shh
secretion. The combined data show that the cranial notochord can
activate Shh signalling and that the early cranial mesoderm is
refractory to Shh signalling.
Fig. 8. The cranial mesoderm is refractory to Shh signalling. Transverse vibratome sections through the presumptive cranial base (A–C and F) or somite (D and E) of HH
stage 13/14 (A–E) and HH stage 15 (F) chick embryos which have been probed for the expression of Ptc1 (A and D), Ptc2 (B, E and F) and Gli1 (C). In (A–C) the trunk
notochord has been grafted into the head whereas in (D–F), the cranial notochord has been grafted into either the trunk (D and E) or head (F). The arrowheads indicate the
ectopic notochord. The black arrows indicate the induction of gene expression and yellow or red arrows indicate the position of the original notochord. nindicates ectopic
expression within the neural tube.
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It has been generally assumed that the molecular mechanisms
required for development of the vertebrae and posterior cranial
base, are conserved. Both arise from paraxial mesoderm in close
proximity to the notochord and ﬂoor plate and the development of
both requires the function of the homeobox gene, Bapx1 (Lettice
et al., 1999; Tribioli et al., 1997). The somitic contribution to the
occipital bone has strengthened this assumption as the occipital
bone is a modiﬁed vertebral element that has expanded to support
the brain (Couly et al., 1992, 1993; Evans and Noden, 2006; Muller
and O’Rahilly, 1994; Kuratani, 2005). However, as stated by Evans
and Noden (2006), the craniofacial mesoderm is a unique region
which is exposed to distinct tissue interactions from the neural
crest and is in close proximity to the endoderm; so, it cannot be
assumed the interactions will be the same. Building on data by Nie
et al., 2005, which showed that Shh and Sox9 are expressed
in adjacent tissues at the time of cranial base induction, we
have examined these assumptions comparing and contrasting
the development of the cranial versus axial skeleton in developing
chick and mouse embryos. We show that a distinct molecular
repertoire controls cranial base development: Pax1, a homeobox
gene required for chondrogenesis in the trunk, is not expressed
in the unsegmented cranial mesoderm and unlike in the trunk,
Bapx1 is expressed prior to activation of the Shh signalling path-
way. Also, in contrast to the trunk, cranial base induction does not
appear to require antagonism of Bmp signalling. However, as in
the trunk, Shh is required for the induction of chondrogenesis.
Finally, we show that development of the cranial base occurs
much later than the axial skeleton and this difference in the timing
of cranial base versus axial skeleton development occurs because
the cranial mesoderm is refractory to Shh signalling.
The onset of chondrogenic differentiation in the cranial base
coincides with the activation of Shh signalling and in the absence
of Hh signalling we did not detect any chondrogenic differentia-
tion within the posterior cranial base. We propose that Hh
signalling is required for the initiation of chondrogenesis within
the developing cranial base. We have also shown that Shh
signalling within the cranial base is required for cell survival as
has been shown in several tissues, including the developing
sclerotome, neural tube, limb bud, prechordal plate and cranial
neural crest cells (Ahlgren and Bronner-Fraser, 1999; Borycki
et al., 1999; Chiang et al., 1996; Aoto et al., 2009). The decrease
in cell survival in Shh deﬁcient embryos may result in the absence
of sufﬁcient chondrogenic progenitors for cranial base develop-
ment. However, in contrast to the neural tube, forebrain, face andlimb, cell death does not appear to be the result of ectopic
repressor forms of Gli3 in the absence of Shh as cranial base
development is not rescued in Shh/Gli3 double mouse mutants
(Aoto et al., 2002, 2009; Litingtung and Chiang, 2000; Litingtung
et al., 2002; te Welscher et al., 2002).
Our analysis of the onset of chondrogenic induction reveals
that cranial base development is initiated later than the axial
skeleton. As we did not observe qualitative differences in the
ability of cranial and caudal notochord to active Shh signalling, it
is curious that there should be this temporal difference in cranial
base development relative to the trunk axial skeleton. We
hypothesize that this relative delay is necessary for the rapid
growth of the developing brain and may also facilitate the co-
ordination of the formation of the anterior and posterior cranial
base that develop from the neural crest and mesoderm respec-
tively. In the chick, neural crest cells start to migrate around HH
stages 9/10 and do not reach their destination until 24 h later at
approximately HH stage 13/14. At HH stage 10, axial skeletal, but
not posterior cranial base, development has already been
initiated. Posterior cranial base development does not begin until
HH stage 17 just after the arrival of the neural crest cells into the
anterior region of the head. The relative delay in cranial base
development may also co-ordinate development of the cranial
base with the neural-crest derived skeletal structures that form
within the pharyngeal arches.
Our studies clearly indicate that the cranial notochord secretes
functionally active Shh and are consistent with the role of Shh in
the notochord and ﬂoor plate during the speciﬁcation of the
ventral otocyst which lies adjacent to the developing cranial base
(Riccomagno et al., 2002). Our data show that the cranial
mesoderm is initially refractory to Hh signalling. The molecular
basis for this regulation remains obscure. This is not simply due to
the absence of the Smoothened receptor, which was detected by
RT-PCR (data not shown) or the presence of known antagonists of
the Shh signalling pathway. As the acrochordal cartilage arises
ﬁrst at the tip of the notochord and adjacent to Rathke’s
pouch—both sources of Shh signalling—we consider an additional
possibility is that quantitative differences in the levels of Shh
signalling not detectable with our notochord graft studies exist.
This possibility would be consistent with the timing of the onset
of cranial base development when Shh is expressed in the
endoderm adjacent to the developing cranial base. Indeed, Shh
is not expressed in the endoderm at HH stage 14 prior to the
initiation of chondrogenesis within the cranial base but tran-
scripts are detectable at stage 17 (compare Supplementary Fig. 2B
and C).
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crest into the forming face and pharyngeal arches. This raised the
possibility that as for cranial myogenic induction, invading neural
crest cells may be required to insulate the presumptive cranial
base from inhibitory signals from the ectoderm and endoderm
(Tzahor et al., 2003). We hypothesised that Bmp and canonical
Wnt signalling pathways could potentially antagonise Shh signal-
ling in the early cranial mesoderm and that these repressive
signals would be counteracted by the migration of neural crest
cells which express Bmp andWnt antagonists (Ladher et al., 2000;
Tzahor et al., 2003). If this were true it would also couple the
induction of cranial myogenesis with that of the cranial base.
However, application of the Bmp antagonist, Noggin, or the Wnt
antagonists, Sfrp2 or Dkk1, failed to activate the Shh pathway
demonstrating that the induction of myogenic and chondrogenic
differentiation are molecularly uncoupled. Furthermore, this
demonstrates that unlike in the trunk, antagonism of Bmp
signalling may not be required for chondrogenic commitment in
the cranial base anlagen. Other candidate antagonists include
retinoic acid signalling. However, retinoic acid signaling varies
throughout the head with high levels in the somites (due to
Raldh2 expression) and very low levels of retinoic acid activity in
the unsegmented cranial mesoderm (due to Cyp26 expression)
(Swindell et al., 1999; Reijntjes et al., 2004). There are graded
levels of retinoic acid activity in the mesoderm adjacent to the
hindbrain. As such, there is no correlation with retinoic acid and
the absence of Shh signaling in the developing occipital somites
and unsegmented cranial paraxial mesoderm. We, therefore,
hypothesize that retinoic acid is unlikely to modulate Shh signal-
ing throughout the cranial mesoderm. Although we favour the
hypothesis that factors expressed by neural crest cells permit the
onset of chondrogenesis, the expression of chondrogenic markers
within the notochord and neural crest cells prevents us from
directly testing this at present, for example by culture of the
presumptive cranial mesoderm and notochord with neural crest
cells or conditioned media derived from neural crest cells.
In the cranial base, following commitment to the chondrogenic
lineage there is a prolonged delay in the onset of terminal
differentiation marked by collagen type X expression (Koyama
et al., 2007). This temporal protraction between commitment and
terminal differentiation has previously been observed for the
developing cranial musculature (Noden et al., 1999) and presum-
ably allows rapid growth of the musculoskeletal system whilst
the head is undergoing considerable expansion and morphoge-
netic change. Terminal differentiation would only occur when
morphogenesis is complete and all the structures have been
established.
Finally we also show that the hedgehog pathway is not
activated during the initial stages of development of the sensory
capsules, the otic, nasal and optic cartilages, in the developing
chick embryo. Supporting our ﬁndings in chicks, we observed
Sox9 expression in the developing otic capsules of Shh-/- mutant
embryos. These observations are consistent with data showing
that Shh is not sufﬁcient to initiate otic capsule development and
TGFb/FGF2 can induce development of the otic capsule (Frenz
et al., 1994; Liu et al., 2002). Furthermore, the nasal septum and
otic capsules are present at E18.5 in Shh-/- mutant mice (Aoto
et al., 2009). FGF, but not Hh, signalling has also been implicated
in the induction of chondrogenesis within cranial neural crest
cells of the developing face (Abzhanov and Tabin, 2004; Sarkar
et al., 2001). Therefore, we conclude that Shh is required for the
induction of the midline skeletal structures of the posterior
cranial base but acts through a signalling network that is distinct
from that in the trunk. The precise timing of cranial base
development may also vary between species being dependent
on the balance of Hedgehog signals from the ﬂoor plate,notochord, cranial ectoderm, endoderm and Hh antagonists. We
also propose that distinct molecular mechanisms have evolved for
the induction of the cartilages of the cranial base, pharyngeal
arches and sensory capsules.Acknowledgements
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